Genome Sequencing and Progressive Supranuclear Palsy

Genome Sequencing and Progressive Supranuclear Palsy

Progressive Supranuclear Palsy (PSP) is a rare and degenerative brain disorder that affects movement, balance, and vision. Although the exact cause of PSP is not fully understood, genetic factors have been implicated in some cases.

Genome sequencing can be used to identify genetic variations that may be associated with PSP. By sequencing the genome of an individual with PSP, researchers can look for variations in genes known to be involved in brain function, movement disorders, or other related pathways. Identifying such variations may help to uncover the genetic basis of the disease and could eventually lead to the development of new treatments.

Recent studies have used genome sequencing to identify potential genetic risk factors for PSP. For example, one study found that variations in the MAPT gene, which codes for the tau protein, are associated with an increased risk of developing PSP. Other studies have identified variations in other genes, such as the STX6 gene, that may also play a role in the disease.

However, it is important to note that genetic factors are only one piece of the puzzle when it comes to PSP. Other factors, such as environmental exposures or lifestyle choices, may also contribute to the development and progression of the disease. Therefore, further research is needed to fully understand the complex interplay of genetic and non-genetic factors in PSP.

Sources;

  • Hoglinger, G. U., et al. (2017). Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nature Genetics, 49(3), 393–399. https://doi.org/10.1038/ng.3779
  • Allen, M., et al. (2018). Genome-wide association study of peripheral neuropathy with Dementia in a subset of the Mayo Clinic Study of Aging. Journal of Alzheimer’s Disease, 62(1), 209–216. https://doi.org/10.3233/JAD-170584
Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • “Handling it well”

    “Handling it well”

    “You handled it so well.” Those words sting, a hollow echo far from my truth. I didn’t handle it. I unraveled, spiraling into the chaos of my own heart. My...

    “Handling it well”

    “You handled it so well.” Those words sting, a hollow echo far from my truth. I didn’t handle it. I unraveled, spiraling into the chaos of my own heart. My...

  • Register Today - Tickets Going Fast! May 3rd in Burlington Ontario

    Register Today - Tickets Going Fast! May 3rd in...

    Time’s ticking to register for our FREE Awareness Walk Starting at The Hub in Burlington Centre! Over 50 of you are already in, and the first 100 to sign up...

    Register Today - Tickets Going Fast! May 3rd in...

    Time’s ticking to register for our FREE Awareness Walk Starting at The Hub in Burlington Centre! Over 50 of you are already in, and the first 100 to sign up...

  • The Challenge of Being One: Helping as Many as Possible

    The Challenge of Being One: Helping as Many as ...

    There’s a quiet weight that comes with wanting to help others when you’re just one person. It’s a desire born from empathy, from seeing the struggles around you and feeling...

    The Challenge of Being One: Helping as Many as ...

    There’s a quiet weight that comes with wanting to help others when you’re just one person. It’s a desire born from empathy, from seeing the struggles around you and feeling...

  • The Unseen Struggle: Advocating for Someone with Atypical Parkinsonism

    The Unseen Struggle: Advocating for Someone wit...

    Living with atypical Parkinsonism is a complex and often misunderstood journey—not just for the person experiencing it, but for those who love and care for them. Unlike classic Parkinson’s disease,...

    1 comment

    The Unseen Struggle: Advocating for Someone wit...

    Living with atypical Parkinsonism is a complex and often misunderstood journey—not just for the person experiencing it, but for those who love and care for them. Unlike classic Parkinson’s disease,...

    1 comment
1 of 4